Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors
Xin, Yan, Jin, Denise, Eppler, Stephen, Damico-Beyer, Lisa A., Joshi, Amita, Davis, John D., Kaur, Surinder, Nijem, Ihsan, Bothos, John, Peterson, Amy, Patel, Premal, Bai, ShuangLanguage:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.148
Date:
August, 2013
File:
PDF, 576 KB
english, 2013